ASX Announcement

CLINUVEL Study to Evaluate SCENESSE as Vitiligo Monotherapy

Published: 20/12/21, 09:25am (AEST)3 pages
Clinuvel Pharmaceuticals Limited
CUV:ASXHealthcare

Recent CUV Announcements

Price Sensitive only